Cargando…
One Year Results of Faricimab for Aflibercept-Resistant Diabetic Macular Edema
PURPOSE: To assess the 12 month outcomes of intravitreal faricimab (IVF) in treatment-resistant diabetic macular edema (DME) recalcitrant to intravitreal aflibercept (IVA). METHODS: This study was undertaken as a retrospective interventional case series of DME subjects receiving care at a single pri...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440101/ https://www.ncbi.nlm.nih.gov/pubmed/37605765 http://dx.doi.org/10.2147/OPTH.S424314 |